The 4C meningococcal B (MenB) vaccine confers modest protection against gonorrhea among adolescents, according to a study published online August 4 in Open Foru ...

The recalled product is labeled Tyenne (tocilizumab-aazg) Injection 400mg/20mL (20mg/mL)20mL vials; Lot# 16UI07; NDC# 65219-594-20; Expiration Date of 08/2028. One lot of Tyenne ® (tocilizumab-aazg) ...

Lonafarnib-based regimens demonstrated statistically significant improvements in week 48 composite virologic and biochemical response rates compared with placebo. The Food and Drug Administration (FDA ...

Ibuprofen 100mg/5mL; susp; berry, grape, or bubble-gum flavor; original or dye-free; alcohol-free. Use appropriate formulation and give every 6–8 hours. <6months ...

Prespecified primary analyses showed significant improvement over placebo in patients aged 71 and older and those with a baseline 6MWD below 333 meters.

In the phase 3 IZAR-1 trial, 42.1% of biologic-naïve adults with active PsA achieved ACR50 at week 16 in the sonelokimab 60mg with induction arm. Topline data were announced from a phase 3 trial ...

HealthDay News — A multistate outbreak of Salmonella infections has been linked to fresh jalapeño peppers imported from Sinaloa, Mexico, according to federal health officials.

Credit: Getty Images. A medical malpractice case study demonstrates how accurate documentation of clinical decline without physician intervention led to an $8 million verdict. Documentation alone does ...

FDA issues CRL due to CMC and facility issues; no clinical data concerns were cited. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to ITM regarding the New Drug ...

The FDA granted Priority Review to the supplemental NDA (sNDA) for levacetylleucine, an orally administered modified amino acid, in the treatment of ataxia-telangiectasia (A-T) in adult and pediatric ...

Federal health officials have launched a nationwide clinical trial to find out whether a drug used to treat diabetes can help veterans cut back on drinking. The US Department of Veterans Affairs (VA) ...

Onabotulinumtoxin A is effective in decreasing headache frequency and disability of chronic migraine in pediatric patients, according to a study published onlin ...